E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/24/2006 in the Prospect News Biotech Daily.

Kyphon gets $300 million revolver

By Sara Rosenberg

New York, Oct. 24 - Kyphon Inc. closed on a new $300 million five-year senior secured revolving credit facility, according to an 8-K filed with the Securities and Exchange Commission Tuesday.

Bank of America acted as lead arranger, bookrunner and administrative agent on the deal. LaSalle Bank acted as syndication agent and Wells Fargo Bank acted as documentation agent.

Pricing on the revolver can range from Libor plus 75 to 125 basis points, based on the company's consolidated leverage ratio.

The revolver, which was completed on Oct. 20, includes a $50 million sublimit for the issuance of standby letters-of-credit, a $25 million sublimit for swingline loans and a $100 million sublimit for multicurrency borrowings.

There is a $100 million accordion feature.

Borrowings are available for general corporate purposes, including acquisitions, capital expenditures and working capital.

Kyphon is a Sunnyvale, Calif.-based medical device company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.